RSS   Newsletter   Contact   Advertise with us
Post Online Media

InMed appoints Andrew Hull to board

InMedInMed Pharmaceuticals, Inc., a biopharmaceutical company, announced that Andrew Hull has been appointed to the board of directors.
Article continues below

READ MORE InMed appoints Martin Bott to board of directors

Mr. Hull's career has spanned over thirty years as a corporate executive in the global healthcare and biotechnology industries, including the last fourteen years at Takeda Pharmaceuticals where he currently serves as the Vice President of Global Alliances.

Mr. Hull has substantial experience in the pharmaceutical industry, with a focus on strategic partnerships and commercialization of prescription drugs.

Additionally, InMed announces it has accepted the resignation of Chris Bogart and Sazzad Hossain as Directors of the Company.

 LATEST MOVES FROM British Columbia 


 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy